Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
- PMID: 38579190
- PMCID: PMC11045270
- DOI: 10.1212/NXI.0000000000200252
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
Erratum for
-
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm. 2022 Nov 21;10(1):e200056. doi: 10.1212/NXI.0000000000200056. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36411076 Free PMC article.
References
-
- Starvaggi Cucuzza C, Longinetti E, Ruffin N, et al. Sustained low relapse rate with highly variable B-cell repopulation dynamics with extended rituximab dosing intervals in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;10(1):e200056. doi: 10.1212/NXI.0000000000200056 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources